Fit-for-Purpose Signal Detection Solutions for Pharmacovigilance
Effective pharmacovigilance demands continuous monitoring of drug safety signals, a critical process that ensures accurate benefit-risk assessment while meeting global regulatory requirements. This paper examines the fundamental importance of signal detection methodologies and describes how Qinecsa’s Signal Detection as a Service (QSDaaS) empowers pharmaceutical teams to implement proactive risk management strategies that enhance patient safety and […]
Building an Automation and AI Culture
Written by Martin Holm-Petersen, Chief Strategy Officer Preamble This will be the first in a series of articles about the application of artificial intelligence (AI) and advanced automation in our industry, with a focus on the pharmacovigilance (PV) use-case. The intention of the series of article is to explain the current state of automation and the issues […]
Get to know our Chief Operating Officer, John Cogan
John Cogan has a degree in chemistry and could easily have become a scientist. However, he was always more fascinated by technology than the laboratory and wanted to explore the space where technology meets science. ‘I’m a scientist with an MBA who’s never worked in a lab!’ With a career that has developed over the […]
Reportum PV Design Studio
Using our PV Design Studio, Reportum offers configurable forms tailored to your use cases and workflows, allowing you to capture data from all sources. With our deep pharmacovigilance expertise, Qinecsa ensures precise data capture tailored to your needs using, delivering data directly to your safety database.
Revolutionizing Literature Screening: Challenges & Innovations
Webinar: Revolutionizing Literature Screening Challenges, Innovations and Future Trends Join us for a focused and dynamic 30-minute webinar where our expert speaker dives into the latest advancements in pharmacovigilance literature screening. Gain actionable insights on overcoming industry challenges, leveraging AI and automation, and understanding emerging trends shaping the future of pharmacovigilance. The session concludes with […]
Join Qinecsa at DIA Europe 2025
Qinecsa is thrilled to be exhibiting at the DIA EU, from March 18-20 2025 in Basel, Switzerland. DIA Europe 2025 will focus on sustainability, innovation and collaboration – three key pillars for shaping the future of healthcare. From the environmental impact of pharmaceuticals and of the drug development lifecycle to sustainable partnerships and sustainable healthcare […]
Industry Outlook 2025 – Part 1: Through the Lens of a Service Provider
Industry Insights – Pharmaceutical Technology talks to Qinecsa Solutions‘ CEO, Adam Sherlock about the outlook for the Life Sciences industry in 2025, focusing in on an increased scrutiny of the cost of health globally, the mega trend of AI and the potential implication for a much broader range of conditions, diseases, and treatment areas using […]
Sign up for the latest Literature Screening webinar! Learn about AI automation and more…
On The Agenda: Introduction Tackling Compliance and Global Challenges: Key regulatory requirements (e.g. EMA) and best practices – Strategies for addressing global surveillance complexities Next- Gen Innovations in Literature Screening: Integration of AI and machine learning to enhance accuracy and efficiency – Role of automation tools in streamlining workflows and improving compliance – Brief examples […]
Join Qinecsa at DIA 2025 Pharmacovigilance & Risk Management Strategies Conference
Qinecsa is thrilled to be exhibiting at the DIA Global Pharmacovigilance & Risk Management Strategies Conference, from January 27-29 2025 in Baltimore, MD. DIA’s Global Pharmacovigilance and Risk Management Strategies Conference is a neutral event developed by regulators and industry experts discussing the updates, opportunities, and challenges alongside fresh problem-solving strategies that matter most to safety […]
PharmaVoice’s Crystal Ball: The industry’s AI future
Thought leadership from Martin Holm-Petersen continues! Qinecsa’s Chief Strategy Officer contributes to PharmaVoice’s 2025 AI Trends Feature. In his contribution, Martin highlights how working with various AI/ML models is critical in leveraging technology to transform drug discovery and development. Read the Full Article
